MIH
CLBT icon

Meitav Investment House’s Cellebrite CLBT Stock Holding History

Meitav Investment House’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,954,846
Closed -$26.9M – 307
2026
Q1 		$26.9M Buy
1,954,846
+500,000
+34% +$7.54M 0.3% 63
2025
Q4 		$26.2M Hold
1,454,846
– – 0.3% 65
2025
Q3 		$27M Hold
1,454,846
– – 0.36% 61
2025
Q2 		$23.3M Sell
1,454,846
-33,435
-2% -$596K 0.31% 58
2025
Q1 		$28.9M Buy
1,488,281
+117,426
+9% +$2.47M 0.53% 47
2024
Q4 		$30.2M Sell
1,370,855
-695,467
-34% -$13.4M 0.51% 54
2024
Q3 		$34.8M Buy
2,066,322
+473,293
+30% +$7.02M 0.58% 49
2024
Q2 		$19M Sell
1,593,029
-99,416
-6% -$1.11M 0.34% 66
2024
Q1 		$18.8M Buy
1,692,445
+1,409,299
+498% +$14.4M 0.37% 65
2023
Q4 		$2.45M Sell
283,146
-32,121
-10% -$250K 0.04% 142
2023
Q3 		$2.4M Buy
+315,267
New +$2.37M 0.04% 148

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Meitav Investment House's CLBT Position: Q2 2026 in Review

Meitav Investment House sold out of Cellebrite (CLBT) in Q2 2026, closing a stake of 1,954,846 shares — an estimated $26.9M sold.

Meitav Investment House first reported a position in CLBT in Q3 2023 and held it in 11 quarters. The position peaked at $34.8M in Q3 2024. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Meitav Investment House reported no remaining Cellebrite position as of Q2 2026 after selling out during the quarter.
  • Meitav Investment House sold 1,954,846 Cellebrite shares in Q2 2026, an estimated $26.9M.
  • Meitav Investment House first reported a position in Cellebrite in Q3 2023 and held it in 11 quarters.
  • Meitav Investment House's Cellebrite position peaked at $34.8M in Q3 2024.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Meitav Investment House's 13F filing for Q2 2026, filed 20 Jul 2026.